newsfilter
← Latest News
PR Newswire·

Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally

JV will have global marketing rights to oral drug delivery technologyHTIT to invest $60 million, Oramed to invest $10 million into JVHTIT to provide a supply agreement for oral insulin capsule JV to advance registration